Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.869 USD | -34.17% | -22.33% | -23.03% |
02:28pm | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
02:16pm | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.03% | 50.33M | |
+7.80% | 111B | |
+11.19% | 106B | |
-12.21% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.77% | 16.81B | |
+38.63% | 12.54B | |
-24.51% | 8.09B |
- Stock Market
- Equities
- BOLT Stock
- News Bolt Biotherapeutics, Inc.
- HC Wainwright Starts Bolt Biotherapeutics at Buy With $8 Price Target